The two main types of cannabinoid receptors are CB1 and CB2. CB1 receptors sit mostly in the brain and nervous system, while CB2 receptors sit mostly on immune cells. Beyond those two, a set of non-classic targets, including GPR55, TRPV1, PPARs, and 5-HT1A, also respond to cannabinoids and help shape how CBD and THC behave in the body.
The classic pair: CB1 and CB2
CB1 and CB2 belong to the G protein-coupled receptor family. They share a similar structure but differ in where they are found and what they do. Both are part of the endocannabinoid system, a signaling network involved in mood, appetite, pain, sleep, and immune response.
Cannabinoid Receptor Buying Guide: How Receptor Science Shapes the CBD You Choose
CB1 receptors
CB1 receptors are among the most abundant G protein-coupled receptors in the brain. They cluster in the cerebral cortex, hippocampus, cerebellum, and basal ganglia, regions tied to memory, movement, and emotion. Smaller numbers appear in the peripheral nervous system, liver, muscle, and gut.
THC binds CB1 and activates it, which is why THC produces psychoactive effects. Anandamide and 2-AG, the body's own endocannabinoids, do the same in smaller, short-lived bursts.
CB2 receptors
CB2 receptors are found mainly on immune cells such as macrophages, B cells, and microglia. They also appear in the spleen, tonsils, and digestive tract. CB2 signaling is studied for its role in inflammation and immune balance. THC binds CB2 as well, but most CB2 activity in the body comes from endocannabinoids rather than from plant compounds.
Other receptor types that respond to cannabinoids
Research has expanded the list well beyond CB1 and CB2. These targets do not always bind THC or CBD directly, yet they help explain the effects people report.
- GPR55 is sometimes called CB3 in older literature. It responds to certain cannabinoids and is studied in bone, pain, and inflammatory pathways.
- TRPV1 is a vanilloid receptor involved in pain and heat sensation. CBD interacts with it, which is one reason it shows up in topical formulas.
- PPAR alpha and gamma are nuclear receptors tied to metabolism and inflammation. Some cannabinoids act on them, and this pathway is a focus of CBD research.
- 5-HT1A is a serotonin receptor. CBD acts as an agonist here, which is one proposed reason CBD may support mood and calm.
- Adenosine and glycine receptors also show indirect cannabinoid activity in some studies.
How CBD fits in
CBD does not bind CB1 or CB2 tightly. Instead, it acts as a negative allosteric modulator at CB1, meaning it changes the receptor's shape and dampens how strongly THC activates it. CBD also inhibits FAAH, the enzyme that breaks down anandamide, so more of the body's own endocannabinoid stays available. Much of CBD's activity happens through TRPV1, 5-HT1A, and PPARs rather than through the classic receptors.
Why receptor types matter when you choose CBD
Receptor activity explains why two products with the same milligram count can feel different. Full-spectrum CBD carries trace THC and other minor cannabinoids that touch CB1 and CB2. CBD isolate works mostly through non-classic targets. Terpenes and flavonoids can also influence how the mixture behaves.
Because these pathways are complex, product quality matters. A lab-tested CBD product comes with a certificate of analysis that confirms the cannabinoid profile, so you know whether CB1-active THC is present and at what level. Reading that report is simple: check total THC, total CBD, and the list of minor cannabinoids.